- Home
- TNGX vs SVA Comparison
TNGX vs SVA Comparison
Compare TNGX & SVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- SVA
- Stock Information
- Founded
- TNGX 2014
- SVA N/A
- Country
- TNGX United States
- SVA
- Employees
- TNGX N/A
- SVA 3261
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- SVA
- Sector
- TNGX Health Care
- SVA
- Exchange
- TNGX Nasdaq
- SVA NYSE
- Market Cap
- TNGX 735.0M
- SVA N/A
- IPO Year
- TNGX N/A
- SVA N/A
- Fundamental
- Price
- TNGX $6.64
- SVA $6.47
- Analyst Decision
- TNGX Strong Buy
- SVA
- Analyst Count
- TNGX 8
- SVA 0
- Target Price
- TNGX $15.14
- SVA N/A
- AVG Volume (30 Days)
- TNGX 885.7K
- SVA N/A
- Earning Date
- TNGX 11-06-2024
- SVA N/A
- Dividend Yield
- TNGX N/A
- SVA N/A
- EPS Growth
- TNGX N/A
- SVA N/A
- EPS
- TNGX N/A
- SVA N/A
- Revenue
- TNGX $42,509,000.00
- SVA N/A
- Revenue This Year
- TNGX $18.15
- SVA N/A
- Revenue Next Year
- TNGX N/A
- SVA N/A
- P/E Ratio
- TNGX N/A
- SVA N/A
- Revenue Growth
- TNGX 26.16
- SVA N/A
- 52 Week Low
- TNGX $6.33
- SVA N/A
- 52 Week High
- TNGX $13.01
- SVA N/A
- Technical
- Relative Strength Index (RSI)
- TNGX 37.15
- SVA N/A
- Support Level
- TNGX $6.83
- SVA N/A
- Resistance Level
- TNGX $7.47
- SVA N/A
- Average True Range (ATR)
- TNGX 0.37
- SVA 0.00
- MACD
- TNGX 0.11
- SVA 0.00
- Stochastic Oscillator
- TNGX 27.31
- SVA 0.00
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.